![Trevor Anthony Mill](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Trevor Anthony Mill
Direttore/Membro del Consiglio presso Biogen Idec Ltd.
Profilo
Trevor Anthony Mill is currently a Director at Biogen Idec Ltd., Convergence Pharmaceuticals Ltd., Silver Acquisition Co. Ltd., Convergence Pharmaceuticals Holdings Ltd., and Old Convergence Pharmaceuticals Ltd.
He previously worked as a Director at Nightstar Therapeutics Ltd.
from 2019 to 2020, Vice President-Regulatory Affairs at Pfizer Inc. from 1999 to 2011, SVP, Head-Global Safety & Regulatory Sciences at Biogen, Inc. from 2011 to 2020, and Senior Manager-Regulatory Affairs & Project at Johnson & Johnson, Inc. from 1995 to 1999.
He will also be the Chief Development Officer at Compass Pathways Plc from 2020 to 2024.
Posizioni attive di Trevor Anthony Mill
Società | Posizione | Inizio |
---|---|---|
Biogen Idec Ltd.
![]() Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Direttore/Membro del Consiglio | 16/04/2012 |
Convergence Pharmaceuticals Holdings Ltd.
![]() Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Part of Biogen, Inc., Convergence Pharmaceuticals Holdings Ltd. functions as an investment holding British company. The company is based in Maidenhead, UK. | Direttore/Membro del Consiglio | - |
Silver Acquisition Co. Ltd.
![]() Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Founded in 2014, Silver Acquisition Co. Ltd. is a biotechnology research and British experimental development company. Part of Biogen, Inc., the company is based in Maidenhead, UK. The company's focus is on developing new biotechnology products through research and experimentation. | Direttore/Membro del Consiglio | 19/12/2014 |
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 06/01/2015 |
Old Convergence Pharmaceuticals Ltd.
![]() Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2010, Old Convergence Pharmaceuticals Ltd. is a subsidiary of Biogen, Inc. that develops analgesics for the treatment of chronic pain. The company is based in Maidenhead, UK. | Direttore/Membro del Consiglio | 11/02/2015 |
Precedenti posizioni note di Trevor Anthony Mill
Società | Posizione | Fine |
---|---|---|
COMPASS PATHWAYS PLC | Corporate Officer/Principal | 01/05/2024 |
BIOGEN INC. | Responsabile della Conformità | 01/12/2016 |
NIGHTSTAR THERAPEUTICS PLC | Direttore/Membro del Consiglio | 31/01/2020 |
PFIZER, INC. | Consigliere Generale | 01/01/2011 |
░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
COMPASS PATHWAYS PLC | Health Technology |
BIOGEN INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 7 |
---|---|
Biogen Idec Ltd.
![]() Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Convergence Pharmaceuticals Holdings Ltd.
![]() Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Part of Biogen, Inc., Convergence Pharmaceuticals Holdings Ltd. functions as an investment holding British company. The company is based in Maidenhead, UK. | Finance |
Silver Acquisition Co. Ltd.
![]() Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Founded in 2014, Silver Acquisition Co. Ltd. is a biotechnology research and British experimental development company. Part of Biogen, Inc., the company is based in Maidenhead, UK. The company's focus is on developing new biotechnology products through research and experimentation. | Health Technology |
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Old Convergence Pharmaceuticals Ltd.
![]() Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2010, Old Convergence Pharmaceuticals Ltd. is a subsidiary of Biogen, Inc. that develops analgesics for the treatment of chronic pain. The company is based in Maidenhead, UK. | Commercial Services |
Nightstar Therapeutics Ltd.
![]() Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Johnson & Johnson, Inc.
![]() Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Johnson & Johnson, Inc. provides insurance brokerage services. The company was founded in 1930 and is headquartered in Mount Pleasant, SC. | Finance |
- Borsa valori
- Insiders
- Trevor Anthony Mill